Degeneration of axons in spinal white matter in G93A mSOD1 mouse characterized by NFL and alpha-internexin immunoreactivity

Abstract Axonal degeneration is a prominent feature of amyotrophic lateral sclerosis (ALS) both in lower motor nerves as well as descending white matter axons in the spinal cord of human patients. Although the pathology of lower motor axonal degeneration has been described in both human ALS and rela...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Brain research 2012-07, Vol.1465, p.90-100
Hauptverfasser: King, Anna E, Blizzard, Catherine A, Southam, Katherine A, Vickers, James C, Dickson, Tracey C
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 100
container_issue
container_start_page 90
container_title Brain research
container_volume 1465
creator King, Anna E
Blizzard, Catherine A
Southam, Katherine A
Vickers, James C
Dickson, Tracey C
description Abstract Axonal degeneration is a prominent feature of amyotrophic lateral sclerosis (ALS) both in lower motor nerves as well as descending white matter axons in the spinal cord of human patients. Although the pathology of lower motor axonal degeneration has been described in both human ALS and related transgenic animal models, few studies have examined the pathological features of descending axon degeneration, particularly in mouse models of ALS. We have examined the degeneration of white matter tracts in the G93A mutant superoxide dismutase-1 (mSOD1+) mouse spinal cord white matter from 12 weeks of age to end-stage disease. In a G93A mSOD1 mouse model where green fluorescent protein was expressed in neurons (mSOD1+/GFP+), degeneration of white matter tracts was present from the ventral to dorsolateral funiculi. This pattern of axonal pathology occurred from 16 weeks of age. However, the dorsal funiculus, the site of the major corticospinal tract in mice, showed relatively less degeneration. Immunohistochemical analysis demonstrated that the neurofilament light chain (NFL) and neuronal intermediate filament protein alpha-internexin accumulated in axon swellings in the spinal white matter. Increased levels of alpha-internexin protein, in mSOD1+ mouse spinal cord tissue, were demonstrated by Western blotting. In contrast, degenerating axons did not show obvious accumulations of neurofilament medium and heavy chain proteins (NFM and NFH). These data suggest that white matter degeneration in this mouse model of ALS is widespread and involves a specific molecular signature, particularly the accumulation of NFL and alpha-internexin proteins.
doi_str_mv 10.1016/j.brainres.2012.05.018
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1024666478</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0006899312008761</els_id><sourcerecordid>1024666478</sourcerecordid><originalsourceid>FETCH-LOGICAL-c425t-884a5ddeaa70aad61c66555dd49db2dfe304b1f710bff900e9d4a54efa9c44883</originalsourceid><addsrcrecordid>eNqNksFu1DAQhiMEokvhFYovSL1ksR3HSS6IqqUFaUUPS8_WxJl0vSTOYmdLl758J9otSFzgZNnz_TPj-SdJTgSfCy70-_W8DuB8wDiXXMg5z-dclM-SmSgLmWqp-PNkxjnXaVlV2VHyKsY1XbOs4i-TIyk1r0pRzJKHC7xFjwFGN3g2tAzuBx-Z8yxunIeO_Vy5EVkP44hher6qsjPWL68vBOuHbURmVxDAUtT9wobVO_b1csHANwy6zQpS5ynk8Z6kru-3fghItLtz4-518qKFLuKbw3mc3Fx--nb-OV1cX305P1ukVsl8TMtSQd40CFBwgEYLq3We04uqmlo2LWZc1aItBK_btuIcq4YECluorFJlmR0np_u8mzD82GIcTe-ixa4Dj_QFI7hUWmtV_BcqZV4ppQnVe9SGIcaArdkE10PYEWQmj8zaPHlkJo8Mzw15RMKTQ41t3WPzW_ZkCgHvDgBEC10bwFsX_3CaFxV1S9zbPdfCYOA2EHOzpEo5GU0tyon4uCeQxnvnMJhoHXqLjQtoR9MM7t_dfvgrhe2cd9TXd9xhXA_bQGtCkzGRNGY57dy0ckJyXhZaZI-rstH5</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1022259446</pqid></control><display><type>article</type><title>Degeneration of axons in spinal white matter in G93A mSOD1 mouse characterized by NFL and alpha-internexin immunoreactivity</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>King, Anna E ; Blizzard, Catherine A ; Southam, Katherine A ; Vickers, James C ; Dickson, Tracey C</creator><creatorcontrib>King, Anna E ; Blizzard, Catherine A ; Southam, Katherine A ; Vickers, James C ; Dickson, Tracey C</creatorcontrib><description>Abstract Axonal degeneration is a prominent feature of amyotrophic lateral sclerosis (ALS) both in lower motor nerves as well as descending white matter axons in the spinal cord of human patients. Although the pathology of lower motor axonal degeneration has been described in both human ALS and related transgenic animal models, few studies have examined the pathological features of descending axon degeneration, particularly in mouse models of ALS. We have examined the degeneration of white matter tracts in the G93A mutant superoxide dismutase-1 (mSOD1+) mouse spinal cord white matter from 12 weeks of age to end-stage disease. In a G93A mSOD1 mouse model where green fluorescent protein was expressed in neurons (mSOD1+/GFP+), degeneration of white matter tracts was present from the ventral to dorsolateral funiculi. This pattern of axonal pathology occurred from 16 weeks of age. However, the dorsal funiculus, the site of the major corticospinal tract in mice, showed relatively less degeneration. Immunohistochemical analysis demonstrated that the neurofilament light chain (NFL) and neuronal intermediate filament protein alpha-internexin accumulated in axon swellings in the spinal white matter. Increased levels of alpha-internexin protein, in mSOD1+ mouse spinal cord tissue, were demonstrated by Western blotting. In contrast, degenerating axons did not show obvious accumulations of neurofilament medium and heavy chain proteins (NFM and NFH). These data suggest that white matter degeneration in this mouse model of ALS is widespread and involves a specific molecular signature, particularly the accumulation of NFL and alpha-internexin proteins.</description><identifier>ISSN: 0006-8993</identifier><identifier>EISSN: 1872-6240</identifier><identifier>DOI: 10.1016/j.brainres.2012.05.018</identifier><identifier>PMID: 22609817</identifier><identifier>CODEN: BRREAP</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Age ; ALS ; Amyotrophic lateral sclerosis ; Amyotrophic Lateral Sclerosis - genetics ; Amyotrophic Lateral Sclerosis - metabolism ; Amyotrophic Lateral Sclerosis - pathology ; Animal models ; Animals ; Axon degeneration ; Axons ; Axons - metabolism ; Axons - pathology ; Biological and medical sciences ; brain ; Data processing ; Development. Senescence. Regeneration. Transplantation ; Disease Models, Animal ; Female ; Fundamental and applied biological sciences. Psychology ; Green fluorescent protein ; Green Fluorescent Proteins - genetics ; Humans ; immunohistochemistry ; Immunoreactivity ; Intermediate Filament Proteins - metabolism ; Intermediate filaments ; Light chains ; Male ; Mice ; Mice, Inbred C57BL ; Mice, Transgenic ; Molecular modelling ; motor neurons ; Motor Neurons - metabolism ; Motor Neurons - pathology ; mutants ; Nerve Degeneration - genetics ; Nerve Degeneration - metabolism ; Nerve Degeneration - pathology ; Nerves ; Neurodegeneration ; Neurofilament Proteins - metabolism ; Neurofilaments ; Neurology ; Neuronal intermediate filament ; Neurons ; patients ; sclerosis ; Spinal cord ; Spinal Cord - pathology ; Spinal Cord - physiopathology ; Spinal Cord Diseases - genetics ; Spinal Cord Diseases - metabolism ; Spinal Cord Diseases - pathology ; Substantia alba ; Superoxide ; superoxide dismutase ; Superoxide Dismutase - genetics ; Superoxide Dismutase - metabolism ; Superoxide Dismutase-1 ; Transgenic animals ; Vertebrates: nervous system and sense organs ; Western blotting</subject><ispartof>Brain research, 2012-07, Vol.1465, p.90-100</ispartof><rights>Elsevier B.V.</rights><rights>2012 Elsevier B.V.</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2012 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c425t-884a5ddeaa70aad61c66555dd49db2dfe304b1f710bff900e9d4a54efa9c44883</citedby><cites>FETCH-LOGICAL-c425t-884a5ddeaa70aad61c66555dd49db2dfe304b1f710bff900e9d4a54efa9c44883</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0006899312008761$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=26079647$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22609817$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>King, Anna E</creatorcontrib><creatorcontrib>Blizzard, Catherine A</creatorcontrib><creatorcontrib>Southam, Katherine A</creatorcontrib><creatorcontrib>Vickers, James C</creatorcontrib><creatorcontrib>Dickson, Tracey C</creatorcontrib><title>Degeneration of axons in spinal white matter in G93A mSOD1 mouse characterized by NFL and alpha-internexin immunoreactivity</title><title>Brain research</title><addtitle>Brain Res</addtitle><description>Abstract Axonal degeneration is a prominent feature of amyotrophic lateral sclerosis (ALS) both in lower motor nerves as well as descending white matter axons in the spinal cord of human patients. Although the pathology of lower motor axonal degeneration has been described in both human ALS and related transgenic animal models, few studies have examined the pathological features of descending axon degeneration, particularly in mouse models of ALS. We have examined the degeneration of white matter tracts in the G93A mutant superoxide dismutase-1 (mSOD1+) mouse spinal cord white matter from 12 weeks of age to end-stage disease. In a G93A mSOD1 mouse model where green fluorescent protein was expressed in neurons (mSOD1+/GFP+), degeneration of white matter tracts was present from the ventral to dorsolateral funiculi. This pattern of axonal pathology occurred from 16 weeks of age. However, the dorsal funiculus, the site of the major corticospinal tract in mice, showed relatively less degeneration. Immunohistochemical analysis demonstrated that the neurofilament light chain (NFL) and neuronal intermediate filament protein alpha-internexin accumulated in axon swellings in the spinal white matter. Increased levels of alpha-internexin protein, in mSOD1+ mouse spinal cord tissue, were demonstrated by Western blotting. In contrast, degenerating axons did not show obvious accumulations of neurofilament medium and heavy chain proteins (NFM and NFH). These data suggest that white matter degeneration in this mouse model of ALS is widespread and involves a specific molecular signature, particularly the accumulation of NFL and alpha-internexin proteins.</description><subject>Age</subject><subject>ALS</subject><subject>Amyotrophic lateral sclerosis</subject><subject>Amyotrophic Lateral Sclerosis - genetics</subject><subject>Amyotrophic Lateral Sclerosis - metabolism</subject><subject>Amyotrophic Lateral Sclerosis - pathology</subject><subject>Animal models</subject><subject>Animals</subject><subject>Axon degeneration</subject><subject>Axons</subject><subject>Axons - metabolism</subject><subject>Axons - pathology</subject><subject>Biological and medical sciences</subject><subject>brain</subject><subject>Data processing</subject><subject>Development. Senescence. Regeneration. Transplantation</subject><subject>Disease Models, Animal</subject><subject>Female</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Green fluorescent protein</subject><subject>Green Fluorescent Proteins - genetics</subject><subject>Humans</subject><subject>immunohistochemistry</subject><subject>Immunoreactivity</subject><subject>Intermediate Filament Proteins - metabolism</subject><subject>Intermediate filaments</subject><subject>Light chains</subject><subject>Male</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Transgenic</subject><subject>Molecular modelling</subject><subject>motor neurons</subject><subject>Motor Neurons - metabolism</subject><subject>Motor Neurons - pathology</subject><subject>mutants</subject><subject>Nerve Degeneration - genetics</subject><subject>Nerve Degeneration - metabolism</subject><subject>Nerve Degeneration - pathology</subject><subject>Nerves</subject><subject>Neurodegeneration</subject><subject>Neurofilament Proteins - metabolism</subject><subject>Neurofilaments</subject><subject>Neurology</subject><subject>Neuronal intermediate filament</subject><subject>Neurons</subject><subject>patients</subject><subject>sclerosis</subject><subject>Spinal cord</subject><subject>Spinal Cord - pathology</subject><subject>Spinal Cord - physiopathology</subject><subject>Spinal Cord Diseases - genetics</subject><subject>Spinal Cord Diseases - metabolism</subject><subject>Spinal Cord Diseases - pathology</subject><subject>Substantia alba</subject><subject>Superoxide</subject><subject>superoxide dismutase</subject><subject>Superoxide Dismutase - genetics</subject><subject>Superoxide Dismutase - metabolism</subject><subject>Superoxide Dismutase-1</subject><subject>Transgenic animals</subject><subject>Vertebrates: nervous system and sense organs</subject><subject>Western blotting</subject><issn>0006-8993</issn><issn>1872-6240</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNksFu1DAQhiMEokvhFYovSL1ksR3HSS6IqqUFaUUPS8_WxJl0vSTOYmdLl758J9otSFzgZNnz_TPj-SdJTgSfCy70-_W8DuB8wDiXXMg5z-dclM-SmSgLmWqp-PNkxjnXaVlV2VHyKsY1XbOs4i-TIyk1r0pRzJKHC7xFjwFGN3g2tAzuBx-Z8yxunIeO_Vy5EVkP44hher6qsjPWL68vBOuHbURmVxDAUtT9wobVO_b1csHANwy6zQpS5ynk8Z6kru-3fghItLtz4-518qKFLuKbw3mc3Fx--nb-OV1cX305P1ukVsl8TMtSQd40CFBwgEYLq3We04uqmlo2LWZc1aItBK_btuIcq4YECluorFJlmR0np_u8mzD82GIcTe-ixa4Dj_QFI7hUWmtV_BcqZV4ppQnVe9SGIcaArdkE10PYEWQmj8zaPHlkJo8Mzw15RMKTQ41t3WPzW_ZkCgHvDgBEC10bwFsX_3CaFxV1S9zbPdfCYOA2EHOzpEo5GU0tyon4uCeQxnvnMJhoHXqLjQtoR9MM7t_dfvgrhe2cd9TXd9xhXA_bQGtCkzGRNGY57dy0ckJyXhZaZI-rstH5</recordid><startdate>20120717</startdate><enddate>20120717</enddate><creator>King, Anna E</creator><creator>Blizzard, Catherine A</creator><creator>Southam, Katherine A</creator><creator>Vickers, James C</creator><creator>Dickson, Tracey C</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>FBQ</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7TK</scope></search><sort><creationdate>20120717</creationdate><title>Degeneration of axons in spinal white matter in G93A mSOD1 mouse characterized by NFL and alpha-internexin immunoreactivity</title><author>King, Anna E ; Blizzard, Catherine A ; Southam, Katherine A ; Vickers, James C ; Dickson, Tracey C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c425t-884a5ddeaa70aad61c66555dd49db2dfe304b1f710bff900e9d4a54efa9c44883</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Age</topic><topic>ALS</topic><topic>Amyotrophic lateral sclerosis</topic><topic>Amyotrophic Lateral Sclerosis - genetics</topic><topic>Amyotrophic Lateral Sclerosis - metabolism</topic><topic>Amyotrophic Lateral Sclerosis - pathology</topic><topic>Animal models</topic><topic>Animals</topic><topic>Axon degeneration</topic><topic>Axons</topic><topic>Axons - metabolism</topic><topic>Axons - pathology</topic><topic>Biological and medical sciences</topic><topic>brain</topic><topic>Data processing</topic><topic>Development. Senescence. Regeneration. Transplantation</topic><topic>Disease Models, Animal</topic><topic>Female</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Green fluorescent protein</topic><topic>Green Fluorescent Proteins - genetics</topic><topic>Humans</topic><topic>immunohistochemistry</topic><topic>Immunoreactivity</topic><topic>Intermediate Filament Proteins - metabolism</topic><topic>Intermediate filaments</topic><topic>Light chains</topic><topic>Male</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Transgenic</topic><topic>Molecular modelling</topic><topic>motor neurons</topic><topic>Motor Neurons - metabolism</topic><topic>Motor Neurons - pathology</topic><topic>mutants</topic><topic>Nerve Degeneration - genetics</topic><topic>Nerve Degeneration - metabolism</topic><topic>Nerve Degeneration - pathology</topic><topic>Nerves</topic><topic>Neurodegeneration</topic><topic>Neurofilament Proteins - metabolism</topic><topic>Neurofilaments</topic><topic>Neurology</topic><topic>Neuronal intermediate filament</topic><topic>Neurons</topic><topic>patients</topic><topic>sclerosis</topic><topic>Spinal cord</topic><topic>Spinal Cord - pathology</topic><topic>Spinal Cord - physiopathology</topic><topic>Spinal Cord Diseases - genetics</topic><topic>Spinal Cord Diseases - metabolism</topic><topic>Spinal Cord Diseases - pathology</topic><topic>Substantia alba</topic><topic>Superoxide</topic><topic>superoxide dismutase</topic><topic>Superoxide Dismutase - genetics</topic><topic>Superoxide Dismutase - metabolism</topic><topic>Superoxide Dismutase-1</topic><topic>Transgenic animals</topic><topic>Vertebrates: nervous system and sense organs</topic><topic>Western blotting</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>King, Anna E</creatorcontrib><creatorcontrib>Blizzard, Catherine A</creatorcontrib><creatorcontrib>Southam, Katherine A</creatorcontrib><creatorcontrib>Vickers, James C</creatorcontrib><creatorcontrib>Dickson, Tracey C</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Neurosciences Abstracts</collection><jtitle>Brain research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>King, Anna E</au><au>Blizzard, Catherine A</au><au>Southam, Katherine A</au><au>Vickers, James C</au><au>Dickson, Tracey C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Degeneration of axons in spinal white matter in G93A mSOD1 mouse characterized by NFL and alpha-internexin immunoreactivity</atitle><jtitle>Brain research</jtitle><addtitle>Brain Res</addtitle><date>2012-07-17</date><risdate>2012</risdate><volume>1465</volume><spage>90</spage><epage>100</epage><pages>90-100</pages><issn>0006-8993</issn><eissn>1872-6240</eissn><coden>BRREAP</coden><abstract>Abstract Axonal degeneration is a prominent feature of amyotrophic lateral sclerosis (ALS) both in lower motor nerves as well as descending white matter axons in the spinal cord of human patients. Although the pathology of lower motor axonal degeneration has been described in both human ALS and related transgenic animal models, few studies have examined the pathological features of descending axon degeneration, particularly in mouse models of ALS. We have examined the degeneration of white matter tracts in the G93A mutant superoxide dismutase-1 (mSOD1+) mouse spinal cord white matter from 12 weeks of age to end-stage disease. In a G93A mSOD1 mouse model where green fluorescent protein was expressed in neurons (mSOD1+/GFP+), degeneration of white matter tracts was present from the ventral to dorsolateral funiculi. This pattern of axonal pathology occurred from 16 weeks of age. However, the dorsal funiculus, the site of the major corticospinal tract in mice, showed relatively less degeneration. Immunohistochemical analysis demonstrated that the neurofilament light chain (NFL) and neuronal intermediate filament protein alpha-internexin accumulated in axon swellings in the spinal white matter. Increased levels of alpha-internexin protein, in mSOD1+ mouse spinal cord tissue, were demonstrated by Western blotting. In contrast, degenerating axons did not show obvious accumulations of neurofilament medium and heavy chain proteins (NFM and NFH). These data suggest that white matter degeneration in this mouse model of ALS is widespread and involves a specific molecular signature, particularly the accumulation of NFL and alpha-internexin proteins.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>22609817</pmid><doi>10.1016/j.brainres.2012.05.018</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0006-8993
ispartof Brain research, 2012-07, Vol.1465, p.90-100
issn 0006-8993
1872-6240
language eng
recordid cdi_proquest_miscellaneous_1024666478
source MEDLINE; Elsevier ScienceDirect Journals
subjects Age
ALS
Amyotrophic lateral sclerosis
Amyotrophic Lateral Sclerosis - genetics
Amyotrophic Lateral Sclerosis - metabolism
Amyotrophic Lateral Sclerosis - pathology
Animal models
Animals
Axon degeneration
Axons
Axons - metabolism
Axons - pathology
Biological and medical sciences
brain
Data processing
Development. Senescence. Regeneration. Transplantation
Disease Models, Animal
Female
Fundamental and applied biological sciences. Psychology
Green fluorescent protein
Green Fluorescent Proteins - genetics
Humans
immunohistochemistry
Immunoreactivity
Intermediate Filament Proteins - metabolism
Intermediate filaments
Light chains
Male
Mice
Mice, Inbred C57BL
Mice, Transgenic
Molecular modelling
motor neurons
Motor Neurons - metabolism
Motor Neurons - pathology
mutants
Nerve Degeneration - genetics
Nerve Degeneration - metabolism
Nerve Degeneration - pathology
Nerves
Neurodegeneration
Neurofilament Proteins - metabolism
Neurofilaments
Neurology
Neuronal intermediate filament
Neurons
patients
sclerosis
Spinal cord
Spinal Cord - pathology
Spinal Cord - physiopathology
Spinal Cord Diseases - genetics
Spinal Cord Diseases - metabolism
Spinal Cord Diseases - pathology
Substantia alba
Superoxide
superoxide dismutase
Superoxide Dismutase - genetics
Superoxide Dismutase - metabolism
Superoxide Dismutase-1
Transgenic animals
Vertebrates: nervous system and sense organs
Western blotting
title Degeneration of axons in spinal white matter in G93A mSOD1 mouse characterized by NFL and alpha-internexin immunoreactivity
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T07%3A48%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Degeneration%20of%20axons%20in%20spinal%20white%20matter%20in%20G93A%20mSOD1%20mouse%20characterized%20by%20NFL%20and%20alpha-internexin%20immunoreactivity&rft.jtitle=Brain%20research&rft.au=King,%20Anna%20E&rft.date=2012-07-17&rft.volume=1465&rft.spage=90&rft.epage=100&rft.pages=90-100&rft.issn=0006-8993&rft.eissn=1872-6240&rft.coden=BRREAP&rft_id=info:doi/10.1016/j.brainres.2012.05.018&rft_dat=%3Cproquest_cross%3E1024666478%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1022259446&rft_id=info:pmid/22609817&rft_els_id=1_s2_0_S0006899312008761&rfr_iscdi=true